Founded in 2011, Covis Pharma is a leading private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses. Our paramount concern is patient outcomes as we focus on improving the health of people with serious medical conditions. Apollo Global Management, with $455 billion assets under management, is the private equity sponsor of Covis Pharma.
Headquartered in Luxembourg with operations in Switzerland, United States, Canada, and the Netherlands, our success is driven by a diverse and experienced team of talented employees worldwide. We operate established therapeutic franchises in respiratory, hospital, and specialty care, through novel commercialization and clinical development strategies. We continue to evolve as a leader in the global healthcare landscape and remain steadfast in our commitment to providing highly efficacious therapeutic solutions to patients at affordable prices.